# Bioequivalence Study of Aripiprazole in Healthy Adult Subjects Under Fasting Condition

> **NCT05532254** · PHASE1 · COMPLETED · sponsor: **Future University in Egypt** · enrollment: 31 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** Aripiprazole 10 mg tablet
- **DRUG:** Abilify® 10 mg tablet

## Key facts

- **NCT ID:** NCT05532254
- **Lead sponsor:** Future University in Egypt
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-14
- **Primary completion:** 2021-03-11
- **Final completion:** 2021-03-11
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2022-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05532254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05532254, "Bioequivalence Study of Aripiprazole in Healthy Adult Subjects Under Fasting Condition". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05532254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*